Pyxis Oncology (PYXS) Prepaid Assets (2020 - 2026)
Pyxis Oncology (PYXS) posted quarterly Prepaid Assets of $3.8 million for Q4 2025, down 6.47% year-over-year from $4.0 million in Q4 2024, and down 29.35% quarter-over-quarter from $5.3 million in Q3 2025.
Pyxis Oncology (PYXS) Prepaid Assets (2020 - 2026) Analysis & Trends
Pyxis Oncology (PYXS) has reported Prepaid Assets for 6 consecutive years, with $3.8 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets fell 6.47% year-over-year to $3.8 million; the TTM figure through Dec 2025 stood at $3.8 million (down 6.47% YoY), while the FY2025 annual figure was $3.8 million, down 6.47% from the prior year.
- Prepaid Assets eased to $3.8 million in Q4 2025 per PYXS's latest filing, from $5.3 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $6.5 million in Q2 2025 and bottomed at $859000.0 in Q3 2021.
- Historically, Prepaid Assets has averaged $4.0 million across 5 years, with a median of $3.9 million in 2024.
- Annual changes were most pronounced in 2021 — Prepaid Assets surged 10621.74% — and 2024, when it sank 44.62%.
- Pyxis Oncology's Prepaid Assets stood at $2.5 million in 2021, then surged by 137.1% to $5.8 million in 2022, then sank by 34.43% to $3.8 million in 2023, then rose by 5.29% to $4.0 million in 2024, then slipped by 6.47% to $3.8 million in 2025.
- Business Quant data shows PYXS's Prepaid Assets at $3.8 million in Q4 2025, $5.3 million in Q3 2025, and $6.5 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pyxis Oncology | 198.37 Mn | 165.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Dec 31, 2025 | 3.78 Mn |
| Sep 30, 2025 | 5.35 Mn |
| Jun 30, 2025 | 6.54 Mn |
| Mar 31, 2025 | 4.97 Mn |
| Dec 31, 2024 | 4.04 Mn |
| Sep 30, 2024 | 2.58 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 3.83 Mn |
| Sep 30, 2023 | 4.66 Mn |
| Jun 30, 2023 | 5.17 Mn |
| Mar 31, 2023 | 5.36 Mn |
| Dec 31, 2022 | 5.85 Mn |
| Sep 30, 2022 | 2.80 Mn |
| Jun 30, 2022 | 1.77 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 859,000.00 |
| Dec 31, 2020 | 23,000.00 |